Patients with epilepsy.
D000342:Affective Symptoms / Q000150:complications; D000367:Age Factors; D000437:Alcoholism / Q000150:complications; D001463:Barbiturates / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D006259:Craniocerebral Trauma / Q000150:complications; D004700:Endocrine System Diseases / Q000150:complications; D004827:Epilepsy / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control; D005334:Fever / Q000150:complications; D006801:Humans; D006985:Hyperventilation / Q000150:complications; D007223:Infant; D010349:Patient Compliance; D010672:Phenytoin / Q000627:therapeutic use; D010775:Photic Stimulation; D011324:Primidone / Q000627:therapeutic use; D012890:Sleep / Q000502:physiology; D012895:Sleep, REM / Q000502:physiology; D013388:Succinimides / Q000627:therapeutic use; D014883:Water-Electrolyte Imbalance / Q000150:complications
D001463:Barbiturates; D013388:Succinimides; D011324:Primidone; D010672:Phenytoin